Literature DB >> 25725153

Masking autoprocessing of Clostridium difficile toxin A by the C-terminus combined repetitive oligo peptides.

Yongrong Zhang1, Therwa Hamza1, Si Gao1, Hanping Feng2.   

Abstract

Clostridium difficile toxin A and B (TcdA and TcdB) are the major virulence factors of the bacterium, both of which consist of two enzymatic domains: an effector glucosyltransferase domain (GTD) and a cysteine protease domain (CPD) responsible for autocleavage and release of GTD. Although the CPDs from both toxins share a similar structure and mechanism of hexakisphosphate (InsP6)-induced activation, TcdA is substantially less sensitive to the autocleavage as compared with TcdB. In this study, we provided evidence of inter-domain regulation of CPD activity of TcdA and its autoprocessing. The C-terminus combined repetitive oligo peptides (CROPs) of TcdA reduced the accessibility of TcdB CPD to its substrate in a chimeric toxin TxB-Ar, consequently blocking autoprocessing. Moreover, interference of antibodies with the CROPs of full-length TcdA efficiently enhanced its GTD release. In conclusion, by utilizing chimeric toxins and specific antibodies, we identified that the CROPs of TcdA plays a crucial role in controlling the InsP6-mediated activation of CPD and autocleavage of GTD. Our data provides insights on the molecular mode of action of the C. difficile toxins.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoprocessing; C-terminus combined repetitive oligo peptides (CROPs); Clostridium difficile; Cysteine protease domain (CPD); Toxin A

Mesh:

Substances:

Year:  2015        PMID: 25725153      PMCID: PMC4426850          DOI: 10.1016/j.bbrc.2015.02.095

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

1.  A novel multivalent, single-domain antibody targeting TcdA and TcdB prevents fulminant Clostridium difficile infection in mice.

Authors:  Zhiyong Yang; Diane Schmidt; Weilong Liu; Shan Li; Lianfa Shi; Jinliang Sheng; Kevin Chen; Hua Yu; Jacqueline M Tremblay; Xinhua Chen; Kurt H Piepenbrink; Eric J Sundberg; Ciaran P Kelly; Guang Bai; Charles B Shoemaker; Hanping Feng
Journal:  J Infect Dis       Date:  2014-03-27       Impact factor: 5.226

2.  Characterization of the cleavage site and function of resulting cleavage fragments after limited proteolysis of Clostridium difficile toxin B (TcdB) by host cells.

Authors:  Maja Rupnik; Stefan Pabst; Marjan Rupnik; Christoph von Eichel-Streiber; Henning Urlaub; Hans-Dieter Söling
Journal:  Microbiology (Reading)       Date:  2005-01       Impact factor: 2.777

3.  Autocatalytic cleavage of Clostridium difficile toxin B.

Authors:  Jessica Reineke; Stefan Tenzer; Maja Rupnik; Andreas Koschinski; Oliver Hasselmayer; André Schrattenholz; Hansjörg Schild; Christoph von Eichel-Streiber
Journal:  Nature       Date:  2007-03-04       Impact factor: 49.962

4.  Autocatalytic processing of Clostridium difficile toxin B. Binding of inositol hexakisphosphate.

Authors:  Martina Egerer; Torsten Giesemann; Christian Herrmann; Klaus Aktories
Journal:  J Biol Chem       Date:  2008-12-01       Impact factor: 5.157

Review 5.  Structure and mode of action of clostridial glucosylating toxins: the ABCD model.

Authors:  Thomas Jank; Klaus Aktories
Journal:  Trends Microbiol       Date:  2008-04-18       Impact factor: 17.079

6.  Cytotoxicity of Clostridium difficile toxin B does not require cysteine protease-mediated autocleavage and release of the glucosyltransferase domain into the host cell cytosol.

Authors:  Shan Li; Lianfa Shi; Zhiyong Yang; Hanping Feng
Journal:  Pathog Dis       Date:  2013-01-14       Impact factor: 3.166

7.  Auto-catalytic cleavage of Clostridium difficile toxins A and B depends on cysteine protease activity.

Authors:  Martina Egerer; Torsten Giesemann; Thomas Jank; Karla J Fullner Satchell; Klaus Aktories
Journal:  J Biol Chem       Date:  2007-06-25       Impact factor: 5.157

8.  Antibody-enhanced, Fc gamma receptor-mediated endocytosis of Clostridium difficile toxin A.

Authors:  Xiangyun He; Xingmin Sun; Jufang Wang; Xiaoning Wang; Quanshun Zhang; Saul Tzipori; Hanping Feng
Journal:  Infect Immun       Date:  2009-03-23       Impact factor: 3.441

9.  A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile.

Authors:  Robert G K Donald; Mike Flint; Narender Kalyan; Erik Johnson; Susan E Witko; Cheryl Kotash; Ping Zhao; Shakuntala Megati; Irina Yurgelonis; Phillip Kwok Lee; Yury V Matsuka; Elena Severina; Anne Deatly; Mini Sidhu; Kathrin U Jansen; Nigel P Minton; Annaliesa S Anderson
Journal:  Microbiology (Reading)       Date:  2013-04-29       Impact factor: 2.777

10.  The combined repetitive oligopeptides of clostridium difficile toxin A counteract premature cleavage of the glucosyl-transferase domain by stabilizing protein conformation.

Authors:  Alexandra Olling; Corinna Hüls; Sebastian Goy; Mirco Müller; Simon Krooss; Isa Rudolf; Helma Tatge; Ralf Gerhard
Journal:  Toxins (Basel)       Date:  2014-07-22       Impact factor: 4.546

View more
  9 in total

1.  Deletion of a 19-Amino-Acid Region in Clostridioides difficile TcdB2 Results in Spontaneous Autoprocessing and Reduced Cell Binding and Provides a Nontoxic Immunogen for Vaccination.

Authors:  Sarah J Bland; Jason L Larabee; Tyler M Shadid; Mark L Lang; Jimmy D Ballard
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

Review 2.  The role of toxins in Clostridium difficile infection.

Authors:  Ramyavardhanee Chandrasekaran; D Borden Lacy
Journal:  FEMS Microbiol Rev       Date:  2017-11-01       Impact factor: 16.408

Review 3.  Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics.

Authors:  Shannon L Kordus; Audrey K Thomas; D Borden Lacy
Journal:  Nat Rev Microbiol       Date:  2021-11-26       Impact factor: 78.297

4.  Crystal structure of Clostridium difficile toxin A.

Authors:  Nicole M Chumbler; Stacey A Rutherford; Zhifen Zhang; Melissa A Farrow; John P Lisher; Erik Farquhar; David P Giedroc; Benjamin W Spiller; Roman A Melnyk; D Borden Lacy
Journal:  Nat Microbiol       Date:  2016-01-11       Impact factor: 17.745

5.  The Conserved Cys-2232 in Clostridioides difficile Toxin B Modulates Receptor Binding.

Authors:  Soo-Young Chung; Dennis Schöttelndreier; Helma Tatge; Viola Fühner; Michael Hust; Lara-Antonia Beer; Ralf Gerhard
Journal:  Front Microbiol       Date:  2018-10-26       Impact factor: 5.640

6.  Structure of the full-length Clostridium difficile toxin B.

Authors:  Peng Chen; Kwok-Ho Lam; Zheng Liu; Frank A Mindlin; Baohua Chen; Craig B Gutierrez; Lan Huang; Yongrong Zhang; Therwa Hamza; Hanping Feng; Tsutomu Matsui; Mark E Bowen; Kay Perry; Rongsheng Jin
Journal:  Nat Struct Mol Biol       Date:  2019-07-15       Impact factor: 15.369

7.  Receptor Binding Domains of TcdB from Clostridioides difficile for Chondroitin Sulfate Proteoglycan-4 and Frizzled Proteins Are Functionally Independent and Additive.

Authors:  Daniel Henkel; Helma Tatge; Dennis Schöttelndreier; Liang Tao; Min Dong; Ralf Gerhard
Journal:  Toxins (Basel)       Date:  2020-11-24       Impact factor: 4.546

Review 8.  Large Clostridial Toxins: Mechanisms and Roles in Disease.

Authors:  Kathleen E Orrell; Roman A Melnyk
Journal:  Microbiol Mol Biol Rev       Date:  2021-06-02       Impact factor: 13.044

9.  Intrinsic Toxin-Derived Peptides Destabilize and Inactivate Clostridium difficile TcdB.

Authors:  Jason L Larabee; Sarah J Bland; Jonathan J Hunt; Jimmy D Ballard
Journal:  MBio       Date:  2017-05-16       Impact factor: 7.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.